Company profile

Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, listed on the Hong Kong Stock Exchange, stock code: 0455) implements the following development strategies: development of Traditional Chinese medicine (“TCM”) as its foundation, development of innovative drugs and medical technologies, as well as development of high-quality medical and healthcare services. It is committed to becoming a competitive pharmaceutical enterprise and core value chain in pharmaceuticals, medical technology, TCM treatment and health management.

More

Financial Reports

Interim Report 2020
Environmental, Social and Governance Report